The APP roles within the firm’s practice
“Advanced Practice Provider” — sometimes called “midlevel provider,” “non-physician practitioner,” or “Advanced Practice Clinician” — describes a range of clinical roles with graduate-level training, prescriptive authority, and clinical decision-making responsibility. The retaliation framework reaches each role on the same statutory terms, with the operative subset of statutes depending on the licensure and the setting.
Family Nurse Practitioners (FNP), Adult-Gerontology NPs (AGNP, AGACNP), Pediatric NPs (PNP), Psychiatric-Mental Health NPs (PMHNP), Women’s Health NPs (WHNP), Acute Care NPs (ACNP), Neonatal NPs (NNP). Licensed under Texas Nursing Practice Act (Tex. Occ. Code Ch. 301) and TBON APRN rules at 22 TAC Ch. 221. Practice under Prescriptive Authority Agreement with delegating physician.
Certified Registered Nurse Anesthetists (CRNAs) in hospital operating rooms, ambulatory surgery centers, pain management clinics, and office-based anesthesia. Surgical First Assists. Work within the Anesthesia Care Team model under anesthesiologist medical direction or independently in some settings under specific arrangements.
PAs across all practice areas — primary care, surgery, emergency medicine, orthopedics, cardiology, oncology, dermatology, and specialty practices. Licensed under Texas Physician Assistant Licensing Act (Tex. Occ. Code Ch. 204), administered by the Texas Physician Assistant Board under TMB oversight at 22 TAC Ch. 185. Practice under supervising physician relationship.
Certified Nurse Midwives (CNMs) in obstetric practice, birthing centers, and hospital labor and delivery. Clinical Nurse Specialists (CNSs) in specialty inpatient settings. Advanced Practice Nurses in research, education, and population-health roles. CRNFA (certified registered nurse first assistants). All operate within APRN licensure under Tex. Occ. Code Ch. 301.
All four groups are within the scope of the multi-statute retaliation framework. For APRNs (NPs, CRNAs, CNMs, CNSs), the Nursing Practice Act and §301.413 retaliation protection applies. For PAs, the PA Licensing Act framework operates, with §301.413 cross-coverage where the PA advises a nurse of reporting rights. All groups have parallel protection under §161.134, §161.135, §260A.014, and the federal frameworks. Many APPs work as locum tenens or contract practitioners — the §161.135 nonemployee retaliation framework is heavily relevant.
The entity universe — and which framework applies where
APPs practice across a wide variety of settings with distinct operational and regulatory structures. The applicable retaliation framework depends on the entity. The settings below cover the major categories.
Hospital-employed NPs and PAs in inpatient medicine, ICU, ED, hospitalist services, surgical first assist, and specialty consult services. Increasingly common as hospital systems integrate APPs into care delivery. The §161.134 framework controls.
§161.134 · §301.413Primary care and specialty group practices employing NPs and PAs alongside physicians. Major Texas employers include Kelsey-Seybold Clinic, Texas Health Physicians Group, Houston Methodist Specialty Physicians Group, Memorial Hermann Medical Group, and large independent specialty groups.
§161.135 · Federal frameworksUrgent care chains and independent operators staffed primarily by NPs and PAs: MedSpring, NextCare, Concentra, FastMed, Texas MedClinic, Little Spurs Pediatric Urgent Care, and others. Production and throughput pressure produces distinctive retaliation patterns.
General employment · §301.413CVS MinuteClinic, Walgreens Health, Walmart Care Clinics, HEB Wellness Centers, and similar retail-based primary care operations. Staffed almost entirely by NPs and PAs. Subject to SOX §806 coverage for publicly-traded parent operators (CVS Health, Walgreens Boots Alliance, Walmart).
General · SOX §806Federally Qualified Health Centers, Rural Health Clinics, community mental health centers. Heavy NP and PA staffing reflects FQHC mission and federal funding structure. NDAA §4712 federal contractor whistleblower protections apply.
§161.134 · NDAA §4712 · FCANP consultancy at SNFs and assisted living facilities, hospital-system-employed NPs covering LTC populations, contracted “SNFist” NP groups. CMS regulations require physician services that NPs frequently provide under delegation. Major operators reflected in the §260A.014 framework.
§260A.014 · §161.135PMHNPs in inpatient psychiatric units, residential treatment centers, IOPs and PHPs, substance use treatment facilities. The §161.134 mental health facility framework and §161.135(c)(1)(C) involuntary commitment retaliation pattern apply. Cross-reference the firm’s behavioral health and therapy staff page.
§161.134 · §161.135NPs and PAs in hospice care, palliative care consult services, home hospice visits, and inpatient hospice units. Medicare Conditions of Participation require interdisciplinary teams. The home visit context surfaces conditions other clinicians would not observe — a high-yield reporting position.
§161.134 (facility-based) · FCAVisiting NPs and PAs serving homebound patients, Medicare-certified home health agencies, in-home behavioral health services, mobile primary care operations.
General · FCA · §301.413Direct-to-consumer telehealth platforms staffed by NPs and PAs: Teladoc Health, Amwell, MDLive, Doctor on Demand, 98point6, and direct-to-consumer telemedicine startups. Texas-specific telehealth requirements under Tex. Occ. Code Ch. 111 affect practice scope.
§161.135 · SOX §806CRNAs in hospital operating rooms, ambulatory surgery centers (ASCs), pain management clinics, and office-based anesthesia. Surgical PA first assists. Major anesthesia practice groups include US Anesthesia Partners (USAP), Envision Healthcare, North American Partners in Anesthesia (NAPA), and academic anesthesia departments.
§161.134 · §161.135 · FCADepartment of Veterans Affairs medical centers (where APRNs have full practice authority under federal regulation), Indian Health Service, Department of Defense military treatment facilities, Federal Bureau of Prisons. NDAA §4712 federal contractor whistleblower protections and the Whistleblower Protection Act apply for federal employees.
NDAA §4712 · WPA · §1983The variety of settings makes APP retaliation analysis fact-intensive at the threshold. The same protected report — patient safety concern, billing fraud, delegating physician misconduct, refusal to perform unsafe care — operates under different combinations of statutes depending on the setting and the APP’s employment status. The firm’s intake process for APP retaliation matters includes early-stage statutory mapping across all applicable frameworks.
The supervision and delegation structure as a retaliation vector
The defining feature of APP practice in Texas — and the feature that distinguishes APP retaliation cases from both nurse and physician cases — is the supervision/delegation structure. APRNs and PAs operate under a written legal relationship with a delegating or supervising physician, and the termination of that relationship is itself a structurally distinct adverse action that can effectively end the APP’s ability to practice at a location.
The Prescriptive Authority Agreement for APRNs
Under Tex. Occ. Code §157.0512, an APRN’s prescriptive authority is governed by a Prescriptive Authority Agreement (PAA) between the APRN and a delegating physician. The PAA must comply with detailed statutory requirements: written delegation of prescriptive authority, defined practice locations and circumstances, periodic chart review (in some practice settings), and specific scope-of-practice provisions. The delegating physician retains the right to terminate the PAA, and the termination is effective with notice.
PAA termination is functionally devastating for an APRN’s practice at the affected location:
- The APRN’s prescriptive authority at that location ends with the PAA
- The APRN cannot independently obtain a new PAA at the location without an alternative delegating physician
- The reason for the PAA termination is rarely required to be specified in writing, leaving the APRN without documentary evidence of the basis
- The PAA termination may not directly affect formal employment status, but the practical consequence is similar to termination of clinical privileges
- NPDB reporting may apply if the PAA termination flows from a reportable adverse action
When PAA termination follows shortly after the APRN’s protected activity — reporting facility misconduct, refusing to prescribe outside clinical judgment, raising concerns about the delegating physician’s practice — the same circumstantial-evidence framework that operates in other healthcare retaliation cases applies. The timing of the PAA termination relative to the protected activity, the absence of prior PAA concerns, and the contrast with similarly situated APRNs whose PAAs were not terminated together support the retaliation inference.
The supervising physician relationship for PAs
Under Tex. Occ. Code Ch. 204 and 22 TAC Ch. 185, PAs practice under a supervising physician relationship. The supervising physician is responsible for the PA’s clinical activities within the delegated scope, and the supervision arrangement is documented in writing as required by the Texas Physician Assistant Board.
Termination of the supervising physician relationship has functionally similar consequences to PAA termination for APRNs: the PA cannot continue to practice at the location without an alternative supervising physician. Where a supervising physician terminates supervision shortly after the PA’s protected activity, the same circumstantial-evidence framework applies.
The PAA / supervision termination is the APP equivalent of a physician peer review action. The physicians page covers the medical staff bylaws as contract framework, HCQIA peer review protections, and NPDB reporting consequences. For APPs, the parallel framework operates through the §157.0512 delegation framework (APRNs) or the Ch. 204 supervision framework (PAs). The firm’s experience in physician peer review litigation transfers directly — the analytical structure for proving retaliatory motive through the delegation/supervision channel is the same as proving retaliatory motive through the peer review channel.
The statutes that protect Advanced Practice Providers
APP retaliation cases routinely involve overlapping statutory frameworks — typically three to four operating concurrently. The major frameworks are summarized below.
For APP employees at hospitals, mental health facilities, and treatment facilities — increasingly common as hospital systems integrate APPs into hospitalist services, ED coverage, ICU care, and specialty consults. The 179-day actionable window under the strict construction of “before the 180th day after” the violation occurred or was discovered includes a built-in discovery rule. The 60-day rebuttable presumption under §161.134(f) shifts the burden of production where the adverse action occurred within 60 days of a good-faith report. The firm’s published Texas appellate authority in SJ Medical Center, LLC v. Anozie is the controlling §161.134 / EFAA decision in Texas.
For contract APPs, locum tenens APPs, and APPs in independent contractor arrangements at hospitals, mental health facilities, and treatment facilities. The Texas Supreme Court’s authority in El Paso Healthcare System v. Murphy itself involved a §161.135 nonemployee case by an independent practitioner — the same procedural posture occupied by many APPs. Section 161.135(c) creates a 60-day rebuttable presumption with four specific retaliation patterns under §161.135(c)(1). The locum tenens market makes §161.135 particularly consequential for APPs.
For APPs at long-term care facilities — NP consultants at SNFs, contracted SNFist NP groups, APPs at assisted living facilities. The §260A.014(a) broad employee definition reaches contract APPs placed at facilities through staffing arrangements. Damages include a $1,000 statutory floor. Limitations: 90 days standard, extendable to 180 days through TWC notice, with a 2-year backstop under §260A.014(h) if the facility failed to obtain the worker’s signed acknowledgment of §260A.014 rights at hire.
The licensure framework for NPs, CRNAs, CNMs, and CNSs. Section 301.413 provides retaliation protection for nurses (including APRNs) who report in good faith and for “a person” who advises a nurse of the nurse’s reporting rights — broadly construed cross-statute protection. Section 301.4025 contains parallel provisions. The 22 TAC Chapter 221 APRN rules establish the regulatory framework for advanced practice including the §157.0512 Prescriptive Authority Agreement framework.
The licensure framework for Physician Assistants. Administered by the Texas Physician Assistant Board under TMB oversight. Establishes the supervising physician relationship that grounds PA practice. PAs who report misconduct by their supervising physician or by the facility face the recurring retaliation vector of supervision termination. The PA Board investigates complaints under specific procedural rules.
APPs bill federal payors directly in many practice settings — Medicare typically reimburses APRNs and PAs at 85% of the physician fee schedule for independently billed services. Billing fraud reports — incident-to billing manipulation, supervision-requirement billing fraud, services not rendered, upcoded encounters — expose the practice to federal False Claims Act (31 U.S.C. §§3729-3733) and Texas Medicaid Fraud Prevention Act (Tex. Hum. Res. Code Ch. 36) liability. Both frameworks include independent anti-retaliation provisions and qui tam (relator) actions.
For APPs at publicly-traded operators — CVS Health, Walgreens Boots Alliance, Walmart (retail clinics), HCA Healthcare, Tenet Healthcare, UHS, Acadia Healthcare (hospital and behavioral health), Teladoc Health, Amwell (telehealth), and others — SOX §806 provides federal whistleblower protection for reports of mail fraud, wire fraud, bank fraud, securities fraud, or violations of SEC rules. SOX §806 has its own 180-day OSHA filing window and damages framework.
For APPs at federally funded operations — Veterans Affairs medical centers, Indian Health Service facilities, federally qualified health centers, Department of Defense military treatment facilities, federal grant-funded programs. NDAA §4712 provides federal contractor whistleblower protection with its own framework and filing window.
The Texas Supreme Court’s Sabine Pilot Service, Inc. v. Hauck, 687 S.W.2d 733 (Tex. 1985), doctrine provides a common-law cause of action for at-will employees terminated for refusing to perform an illegal act carrying criminal penalties. For APPs, common Sabine Pilot scenarios include refusing to prescribe outside clinical judgment, refusing to falsify chart documentation, refusing to bill for services not rendered, refusing to participate in incident-to billing fraud, refusing to provide care outside scope of practice, and refusing to administer treatments that would constitute injury to disabled or elderly patients under Tex. Penal Code §22.04.
The Texas restrictive APRN framework as a structural vulnerability
The Texas APRN practice authority framework is among the most restrictive in the United States. Unlike the 27 states and the District of Columbia that have adopted Full Practice Authority for APRNs, Texas requires APRNs to maintain a written delegation arrangement with a physician for prescriptive authority. The restriction has consequences for the retaliation framework.
The structural vulnerability operates in several ways:
The APRN cannot easily relocate practice within the state. The PAA structure means that finding a delegating physician is a necessary precondition to practice at any new location. APRNs who report misconduct at one practice face structural barriers to finding alternative employment if the prior delegating physician is unwilling to provide a positive reference or if the retaliation includes negative communications to potential delegating physicians at other practices.
The regional delegating physician market is finite. In smaller Texas markets, the pool of physicians willing to serve as delegating physicians for a given APRN specialty may be limited. Retaliation that closes off the existing delegation may foreclose meaningful regional alternatives.
Practice acquisition by hospital systems concentrates the delegating physician market. Where a hospital system employs both the APRN and the delegating physician, the system controls both ends of the delegation arrangement. A system-driven retaliation can simultaneously terminate the APRN’s employment and the PAA, with the delegating physician’s signature on the PAA termination making the action appear to flow from the physician’s independent professional judgment rather than from corporate retaliation.
The framework has been challenged but remains in place. Texas APRN groups and broader healthcare policy organizations have advocated for Full Practice Authority. The current restrictive framework reflects historical legislative compromise between physician and APRN interests. The retaliation framework operates against this restrictive backdrop.
The Texas Supreme Court’s good-faith standard from El Paso Healthcare System, Ltd. v. Murphy, 518 S.W.3d 412 (Tex. 2017), applies to APP retaliation reports the same way it applies to other healthcare retaliation contexts. The APP need not prove that the reported conduct actually violated the law — only that the APP had a good-faith belief that it did, grounded in the APP’s training, experience, and direct observation.
Refusal to prescribe and the protected-activity framework
APRNs and PAs both have prescriptive authority subject to the delegation/supervision framework and to applicable federal and state controlled substance law. The corresponding-responsibility framework that applies to pharmacists under 21 CFR 1306.04 operates in similar fashion for APPs writing controlled substance prescriptions — the prescriber must determine that the prescription is issued for a legitimate medical purpose by an individual practitioner acting in the usual course of professional practice.
Where the APP exercises clinical judgment and declines to write a particular prescription — for an inappropriate indication, for an unsupported dose or duration, for a patient with apparent drug-seeking behavior, or for a treatment outside the APP’s scope of practice — the refusal is protected activity. Owner or management pressure to prescribe despite the APP’s clinical judgment can produce retaliation patterns parallel to the pharmacist refusal-to-fill pattern:
- The APP refuses to write a prescription based on clinical judgment
- The owner, supervising physician, or facility characterizes the refusal as “customer service failure,” “lack of collaboration,” or “scope-of-practice issue”
- The APP is disciplined or terminated, sometimes immediately, sometimes through accumulated contrived performance issues
- The pattern triggers protection under §161.134 / §260A.014 / §161.135 (where applicable), Sabine Pilot common law (where prescribing would have constituted a CSA violation), and parallel federal frameworks
The refusal-to-prescribe pattern is particularly pronounced in pain management practices, urgent care chains, and high-volume primary care settings where prescriptive pressure operates against the APP’s clinical judgment. The DEA red-flag framework, the corresponding-responsibility doctrine, and the APP’s scope-of-practice obligations together support the protected nature of the refusal.
National Practitioner Data Bank reporting for APPs
The National Practitioner Data Bank reports adverse actions taken against practitioners with clinical privileges, including APRNs and PAs in many settings. Like physicians, APPs face significant collateral consequences from NPDB reports — the report follows the practitioner across state lines, affects future employment and credentialing, and can be discovered by insurers, regulators, and prospective employers.
NPDB-reportable actions affecting APPs include:
- Adverse actions involving clinical privileges of more than 30 days
- Professional society membership actions
- State licensing actions including reprimands, suspensions, revocations, and limitations on practice
- Malpractice payments made on the APP’s behalf
- Healthcare-related criminal convictions and civil judgments
Retaliatory NPDB reports — reports of adverse actions where the underlying action was retaliation rather than genuine clinical concern — can be challenged through several mechanisms:
Secretary review under 42 CFR Part 60. A practitioner who believes a report contains incorrect information can request that the reporting entity correct the report. If the entity does not correct the report, the practitioner can request Secretary review through the Health Resources and Services Administration.
NPDB voiding through legal proceedings. Where the underlying adverse action is determined to be retaliatory or otherwise invalid through legal proceedings, the NPDB report can be voided. The firm’s experience in physician retaliation cases includes successful NPDB voiding through the §161.134 / HCQIA framework — the same analytical structure applies to APP NPDB reports.
Coordinated litigation. Where the retaliation litigation, the licensing board defense, and any potential NPDB challenge are coordinated from the start, the work in each forum supports the work in the others. Inconsistent positions across forums can create complications that early counsel involvement avoids.
Patterns of retaliation against APPs
APP retaliation is rarely framed as retaliation. It is framed as a “delegation/supervision concern,” a “scope-of-practice” issue, a “collaboration” failure, or a “production” deficiency. The patterns that recur with enough frequency to be treated as a doctrinal category include:
The defining APRN retaliation pattern. The delegating physician terminates the PAA, ending the APRN’s prescriptive authority at the location. The termination is characterized as the physician’s independent professional judgment but functionally operates as retaliation where the temporal proximity, the absence of prior PAA concerns, and the contrast with similarly situated APRNs together support the inference. The PAA termination is itself an adverse action under §161.134(a) / §161.135 regardless of whether formal employment continues.
The defining PA retaliation pattern. The supervising physician terminates the supervision arrangement, ending the PA’s ability to practice at the location. Functionally identical in consequence to PAA termination, operating through the Tex. Occ. Code Ch. 204 / 22 TAC Ch. 185 PA supervision framework.
The facility or supervising physician characterizes the APP’s clinical decisions as “exceeding scope” or “practicing medicine without a license.” The characterization is particularly insidious because it weaponizes the APP-physician scope distinction. The Texas Supreme Court’s good-faith standard from Murphy protects clinical decision-making within the APP’s training and certification, and the documentary record of the APP’s prior similar clinical decisions typically rebuts the post-report scope-of-practice characterization.
A flexible chain pharmacy retaliation pretext adapted to APP practice. The APP’s compliance-based decisions — refusing to prescribe outside clinical judgment, advocating for patient referral or specialist consult, raising concerns about the delegating physician’s practice — are characterized as “failure to collaborate.” Collaboration is the APP’s general professional obligation, but specific clinical decisions are not subject to override by the delegating physician on the basis of “collaboration.”
Particularly prevalent in retail clinic and urgent care settings. The APP raises a concern about staffing inadequacy, prescribing pressure, refusal-to-prescribe standards, or care quality; the chain responds by characterizing the worker’s prior performance as deficient on production metrics (encounters per hour, wait time, customer service scores). The recharacterization is vulnerable to circumstantial-evidence challenge — the production data typically does not reflect any change in performance, only a change in how the data is being characterized. Salas v. Fluor Daniel provides the directly transferable Texas authority.
The facility files a complaint against the APP with the Texas Board of Nursing (APRNs) or the Texas Physician Assistant Board (PAs). The complaint imposes investigation costs, professional reputation damage, and potential disciplinary consequences. The same evidence that proves the underlying §161.134 / §161.135 retaliation typically supports the board defense. The firm coordinates the two proceedings, with attention to NPDB consequences that may flow from board action.
The APP is not terminated but is scheduled at incompatible times, given no patient assignments, removed from on-call rotation, or assigned to locations the APP cannot reach. The functional effect is constructive discharge. The scheduling changes are characterized as routine operational decisions but follow shortly after protected activity and contrast sharply with the prior scheduling pattern.
After the protected report, the facility documents complaints from patients or family members about the APP — complaints that did not exist before. Patient experience scores are typically aggregate metrics that do not isolate specific clinical interactions, making the pretext both flexible and vulnerable to circumstantial-evidence challenge through the temporal proximity, the absence of pre-report complaints, and the consistency of the new complaints with the retaliation timeline.
The facility makes an NPDB-reportable adverse action against the APP — a clinical privilege restriction of more than 30 days, a termination characterized as based on clinical concerns, or a referral to the Texas Board of Nursing or Texas PA Board that may itself produce a reportable result. The NPDB consequences attach across state lines and affect future practice. The challenge framework includes Secretary review, civil litigation, and coordinated defense across forums.
For locum tenens APPs and contract APPs, the most common retaliation pattern is non-renewal of the contract or termination of the locum assignment shortly after the protected activity. The §161.135 nonemployee framework applies, with the 60-day rebuttable presumption. Joint employer doctrine may extend liability to both the staffing entity and the facility.
The damages framework in APP retaliation cases
The damages framework depends on which statutes operate concurrently. For most APP retaliation cases, the operative frameworks include §161.134 (hospital) or §260A.014 (LTC) or §161.135 (nonemployee/locum), §301.413 (nurse-advisor) where applicable, FCA / Texas MFPA where billing fraud is involved, possibly SOX §806 or NDAA §4712, and Sabine Pilot for refusal-to-prescribe cases.
Several aspects of the damages framework deserve attention in the APP context:
Specialized credentials and limited replacement markets
APRNs hold Master of Science in Nursing or Doctor of Nursing Practice degrees with specialty certification (American Nurses Credentialing Center, American Association of Nurse Practitioners, AANA for CRNAs, AMCB for CNMs, NCCPA for PAs). The credentialing investment is substantial. Specialty practice areas (psychiatric, neonatal, oncology) have limited regional replacement markets, and the Texas restrictive APRN framework concentrates the regional delegating physician market in ways that compound replacement-employment difficulty.
The PAA termination as a career-altering event
For APRNs, PAA termination affects future practice in ways that extend beyond the immediate position. Future prospective delegating physicians often inquire about prior PAA terminations, and the inability to provide an unqualified explanation can affect new PAA arrangements. The future-earnings analysis in APRN retaliation cases reflects this longer-term consequence.
NPDB reporting as future-earnings constraint
NPDB reports follow the APP across state lines and across employment opportunities. Credentialing committees at hospitals, managed care contracts, and licensing bodies all access the NPDB. The reputation effects of an NPDB report can foreclose specialty practice opportunities and reduce regional employment alternatives. Damages may include the cost of NPDB challenge proceedings.
Mental anguish damages
Multiple operative statutes authorize mental anguish damages standing alone — §161.134(c), §260A.014(b)(1), §161.135, §301.413. The APP context produces distinctive dignitary harm: the worker’s professional identity is bound up with patient care, and being targeted for retaliation by the delegating or supervising physician — the very physician whose professional judgment was supposed to support the APP’s practice — carries particular weight.
Exemplary damages
Multiple operative statutes authorize exemplary damages. The Texas standard under Ancira Enterprises, Inc. v. Fischer, 178 S.W.3d 82 (Tex. App.—Austin 2005, no pet.), requires awareness that the conduct is or may be violating the law. Healthcare facilities are subject to extensive anti-retaliation training requirements, and corporate witnesses routinely concede in deposition that they had specific training on the relevant statutes.
FCA qui tam recovery
For APP retaliation cases involving billing fraud — incident-to billing manipulation, supervision-requirement fraud, services not rendered, upcoded encounters — the worker may have qui tam relator standing under the federal False Claims Act. The relator share is typically 15-25% if the government intervenes and 25-30% if not. The qui tam recovery is separate from and additive to the worker’s individual damages.
The structural significance of APP retaliation cases
APP retaliation cases are often more consequential than the underlying employment dispute would suggest. Several features warrant attention.
APPs are increasingly central to healthcare delivery. The U.S. healthcare workforce includes hundreds of thousands of NPs, CRNAs, CNMs, CNSs, and PAs. APPs deliver primary care, urgent care, behavioral health care, surgical anesthesia, and specialty consult services to populations that physicians alone could not adequately serve. Retaliation against APPs has systemic consequences for healthcare access in ways that retaliation against any single physician typically does not.
The supervision/delegation structure creates structural retaliation vulnerability. Unlike physicians who hold independent practice authority, APPs depend on the delegation/supervision relationship for their ability to practice. The structural dependence is built into the regulatory framework and is not the product of contracting around the framework. Retaliation that operates through the delegation/supervision channel is therefore qualitatively different from retaliation against independent practitioners — and the legal framework needs to account for this difference.
The NPDB consequences are amplified. Where retaliation includes an NPDB-reportable adverse action, the consequences extend beyond the immediate position to affect future practice across state lines. The combined exposure to retaliation litigation, licensing board defense, and NPDB challenge creates complex parallel proceedings that benefit from coordinated handling from the start.
The locum tenens market makes §161.135 particularly important. A substantial portion of the APP workforce operates as locum tenens or contract clinicians. The §161.135 nonemployee retaliation framework — anchored by the Texas Supreme Court’s Murphy decision in a §161.135 nonemployee context — is therefore central to APP retaliation practice. The four-pattern presumption under §161.135(c)(1), including the unique §161.135(c)(1)(C) involuntary commitment pattern (particularly relevant for PMHNPs and behavioral health APPs), provides procedural advantages that exceed those available to direct employees in some respects.
The retail clinic and urgent care expansion has created new retaliation contexts. The growth of CVS MinuteClinic, Walgreens Health, Walmart Care Clinics, and similar retail healthcare operations has created new APP employment contexts with distinctive retaliation patterns — particularly around production metrics, prescribing pressure, and the chain-pharmacy-style understaffing concerns that affect chain pharmacy. The SOX §806 coverage of publicly-traded operators in this space provides parallel federal whistleblower protection.
How the firm approaches APP retaliation matters
Doyle Dennis Avery LLP represents Advanced Practice Providers — NPs, CRNAs, CNMs, CNSs, and PAs — across the full range of practice settings in retaliation matters where the conduct was egregious and the documentary record supports a strong evidentiary case. The firm’s practice is selective by design: these matters require careful multi-statute claim development, regulatory-record discovery across the §161.134 / §260A.014 / §161.135 / TBON / Texas PA Board frameworks, expert work on APP standards of practice (the Texas Nursing Practice Act and TBON APRN rules, the PA Licensing Act and Texas PA Board rules, the §157.0512 Prescriptive Authority Agreement framework, scope-of-practice analyses), parallel coordination with any licensing board defense and NPDB challenge, and frequent joint-employer analysis where locum or contract APP staffing structures are involved.
Two of the firm’s named partners are board certified by the Texas Board of Legal Specialization. Jeffrey Avery is board certified in Labor and Employment Law. Michael Patrick Doyle is board certified in Personal Injury Trial Law. The firm’s published Texas appellate authority in SJ Medical Center, LLC v. Anozie is the controlling §161.134 / EFAA decision in Texas. The firm’s published Texas appellate authority in Salas v. Fluor Daniel Services Corp., 616 S.W.3d 137, addresses the reduction-in-force, “scope of practice,” and “performance” pretexts that recur in APP termination cases. The firm’s $375,681 Final Award in the Sea Breeze §260A.014 arbitration and the $1.7M verdict in Ball v. Alleyton anchor the damages framework. The firm’s physician retaliation practice includes NPDB voiding experience that transfers directly to APP NPDB challenge work.
The firm’s intake process for APP retaliation matters typically opens with a confidential initial consultation, followed by documentation review (the protected-activity record across all relevant frameworks, the adverse-action timeline including any PAA or supervision termination, the worker’s licensure history and any prior board interactions, employment paperwork including arbitration agreement and §260A.014(h) signed-acknowledgment analysis where applicable, any parallel board complaint documentation, any NPDB report or report-eligible action, and the documentation of the delegating or supervising physician relationship), and a written intake analysis identifying the operative statutes, the cumulative presumption analysis, the limitations posture across each framework, the EFAA analysis where the underlying conduct involves any sexual misconduct dimension, the FCA / Texas MFPA analysis where billing fraud is involved, and the procedural sequencing including coordination with any parallel board defense and NPDB work. Where the matter meets the firm’s criteria, representation proceeds on a contingency basis.
The firm represented the appellee in an interlocutory appeal from denial of motion to compel arbitration. The decision applies to APP retaliation matters where the underlying conduct involves any sexual misconduct dimension, providing controlling Texas appellate authority for defeating compelled arbitration of §161.134 retaliation claims. Hospital-employed NPs, PAs, and APRN/PA leadership in any clinical area where patient-on-staff, staff-on-patient, or staff-on-staff sexual misconduct surfaces have the EFAA pathway available.
Workers’ compensation retaliation case where the trial court had granted summary judgment on the employer’s reduction-in-force defense. The Court of Appeals reversed and remanded. The published opinion is among the strongest Texas appellate authorities for piercing facially neutral RIF, “scope of practice,” “performance,” and contract-non-renewal pretexts — directly applicable to APP retaliation cases.
Workers’ compensation retaliation matter. Verdict included $750,000 in exemplary damages on a gross negligence finding. The proof framework — circumstantial-evidence retaliation proof through documentary contradiction, witness inconsistency, and policy-based cross-examination — transfers directly to APP retaliation cases involving PAA termination, scope-of-practice pretext, and production-metrics characterizations.
§260A.014 long-term care retaliation matter on behalf of two co-claimants. The arbitrator entered a Final Award including past and future wage loss, past mental anguish, prejudgment interest, attorney’s fees, paralegal fees, and recoverable costs and expenses — applicable to APP retaliation matters where §260A.014 is the operative setting-based framework (NP consultants at SNFs, contracted SNFist groups, APPs at assisted living facilities, PPECCs).
§260A.014 representation at a federally funded ORR facility. The matter illustrates the §260A.014 / NDAA §4712 parallel framework available where federal grant funding overlays the state regulatory framework — directly applicable to APPs at federally funded healthcare operations including FQHCs, VA medical centers, and federally funded children’s facilities.
Whistleblower retaliation matter. A unanimous jury returned $1.1 million on a willful violation finding; final judgment, including prejudgment interest, costs, and statutory attorney’s fees, totaled approximately $1.97 million. The damages framework transfers to all retaliation matters including APP practice.
Invited presentations by trial counsel addressing circumstantial-evidence retaliation proof transferable across statutory frameworks — including the multi-statute APP context.
What APPs ask about retaliation rights
What statutes protect Advanced Practice Providers from retaliation in Texas?
My delegating physician terminated my Prescriptive Authority Agreement after I raised concerns — is that retaliation?
I’m a Nurse Practitioner — are my protections different from those for an RN?
I’m a CRNA — what’s the framework when the anesthesia care team turns against me?
I’m a Physician Assistant — does the PA Practice Act protect me?
Will my termination be reported to the NPDB?
I work as a locum tenens APP — am I protected?
I work at a retail clinic — does the framework reach me?
What if my employer files a complaint against me with the Texas Board of Nursing or the Texas PA Board?
What damages can I recover?
How long do I have to bring a claim?
The delegation and supervision frameworks are not retaliation tools. Texas law makes sure of that.
If you are a Nurse Practitioner, CRNA, CNM, CNS, or Physician Assistant who has been terminated, suspended, had a Prescriptive Authority Agreement terminated, lost supervising physician arrangement, faced a retaliatory board complaint, been NPDB-reported, or been pressured to resign after reporting patient safety concerns, billing fraud, prescribing pressure, supervising physician misconduct, or other violations of law at a hospital, physician practice, urgent care, retail clinic, FQHC, long-term care facility, behavioral health facility, hospice, home health, telehealth platform, surgical setting, or federal practice operation, you may have claims under multiple Texas statutes — typically a setting-based framework (§161.134, §161.135, or §260A.014) plus §301.413 nurse-advisor protection, FCA / Texas MFPA qui tam protections, SOX §806 for publicly-traded operators, and Sabine Pilot common law. Consultations are confidential and free. The §161.134(h) actionable window is 179 days under the strict construction. Early counsel involvement matters substantially — particularly where parallel board proceedings or NPDB consequences are involved.
Speak with our team →